Spectral AI Raises $7.6 Million in Institutional Funding Round
Spectral AI, Inc. (Nasdaq: MDAI), an artificial intelligence company specializing in medical diagnostics for wound care, has announced the pricing of a $7.6 million offering to support the continued development and expansion of its DeepView® System. The financing includes the issuance of 4,000,000 shares of common stock and pre-funded warrants at $1.90 per share, along with accompanying warrants exercisable at $2.51 per share. The funds will be used to advance the company's AI-powered technology, expand clinical indications, and prepare for commercial readiness in 2026. Northland Capital Markets served as the exclusive placement agent, and Reed Smith, LLP acted as counsel for the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9550953-en) on October 23, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。